IRRAS Crecimiento futuro
Future controles de criterios 2/6
IRRAS is forecast to grow earnings and revenue by 96.4% and 84.7% per annum respectively.
Información clave
96.4%
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 15.7% |
| Tasa de crecimiento de los ingresos | 84.7% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 03 Jan 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2024 | 249 | -30 | N/A | N/A | 1 |
| 12/31/2023 | 165 | -101 | N/A | N/A | 1 |
| 6/30/2023 | 43 | -196 | -195 | -192 | N/A |
| 3/31/2023 | 43 | -193 | -197 | -193 | N/A |
| 12/31/2022 | 40 | -167 | -179 | -176 | N/A |
| 9/30/2022 | 37 | -164 | -160 | -157 | N/A |
| 6/30/2022 | 32 | -141 | -133 | -129 | N/A |
| 3/31/2022 | 27 | -131 | -134 | -129 | N/A |
| 12/31/2021 | 22 | -136 | -138 | -131 | N/A |
| 9/30/2021 | 18 | -131 | -131 | -123 | N/A |
| 6/30/2021 | 14 | -135 | -134 | -125 | N/A |
| 3/31/2021 | 10 | -140 | -139 | -129 | N/A |
| 12/31/2020 | 7 | -136 | -141 | -133 | N/A |
| 9/30/2020 | 8 | -134 | -151 | -144 | N/A |
| 6/30/2020 | 7 | -139 | -159 | -152 | N/A |
| 3/31/2020 | 7 | -147 | -166 | -152 | N/A |
| 12/31/2019 | 5 | -151 | -169 | -154 | N/A |
| 9/30/2019 | 2 | -165 | -159 | -138 | N/A |
| 6/30/2019 | 1 | -171 | -146 | -125 | N/A |
| 3/31/2019 | 0 | -160 | -130 | -116 | N/A |
| 12/31/2018 | 6 | -139 | -112 | -97 | N/A |
| 9/30/2018 | 7 | -112 | -103 | -95 | N/A |
| 6/30/2018 | 18 | -78 | -90 | -82 | N/A |
| 3/31/2018 | 18 | -67 | -78 | -68 | N/A |
| 12/31/2017 | 12 | -61 | -65 | -54 | N/A |
| 9/30/2017 | 11 | -48 | -53 | -35 | N/A |
| 12/31/2016 | N/A | -32 | N/A | -18 | N/A |
| 12/31/2015 | N/A | -13 | N/A | -11 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: 4Z7 is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: 4Z7 is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: 4Z7 is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: 4Z7's revenue (84.7% per year) is forecast to grow faster than the German market (4.7% per year).
Ingresos de alto crecimiento: 4Z7's revenue (84.7% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if 4Z7's Return on Equity is forecast to be high in 3 years time